Association of fluconazole pharmacodynamics with mortality in patients with candidemia

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 6, 2009, Pages 2704-2705

  Arendrup, Maiken C ^a   Cuenca Estrella, Manuel ^b   Donnelly, J Peter ^c   Lass Flörl, Cornelia ^d   Rodriguez Tudela, Juan L ^b  

^a STATENS SERUM INSTITUT   (Denmark)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

FLUCONAZOLE;

ANTIFUNGAL SUSCEPTIBILITY; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CANDIDEMIA; HUMAN; LETTER; MINIMUM INHIBITORY CONCENTRATION; MORTALITY; PHARMACODYNAMICS; PRIORITY JOURNAL; QUALITY CONTROL;

ANTIFUNGAL AGENTS; CANDIDA; CANDIDIASIS; FLUCONAZOLE; FUNGEMIA; HUMANS; MICROBIAL SENSITIVITY TESTS;

EID: 67049171054     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01411-08     Document Type: Letter

References (4)

1. Arendrup, M., T. Horn, and N. Frimodt-Møller. 2002. In vivo pathogenicity of eight medically relevant Candida species in an animal model. Infection 30:286-291.
2. Baddley, J. W., M. Patel, S. M. Bhavnani, S. A. Moser, and D. R. Andes. 2008. Association of fluconazole pharmacodynamics with mortality in patients with candidemia. Antimicrob. Agents Chemother. 52:3022-3028.
3. National Committee for Clinical Laboratory Standards. 2002. Reference method for broth dilution antifungal susceptibility testing of yeasts. M27-A2. National Committee for Clinical Laboratory Standards, Wayne, PA.
4. Ostrosky-Zeichner, L., J. H. Rex, M. A. Pfaller, D. J. Diekema, B. D. Alexander, D. Andes, S. D. Brown, V. Chaturvedi, M. A. Ghannoum, C. C. Knapp, D. J. Sheehan, and T. J. Walsh. 2008. Rationale for reading fluconazole MICs at 24 hours rather than 48 hours when testing Candida spp. by the CLSI M27-A2 standard method. Antimicrob. Agents Chemother. 52:4175-4177.